Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.

MMWR. Morbidity and mortality weekly report - 17 Dec 2021

Abstract excerpt

A new variant of SARS-CoV-2 (the virus that causes COVID-19), B.1.1.529 (Omicron) (1), was first reported to the World Health Organization (WHO) by South Africa on November 24, 2021. Omicron has numerous mutations with potential to increase transmissibility, confer resistance to therapeutics, or partially escape infection- or vaccine-induced immunity (2). On November 26, WHO designated B.1.1.529 as a variant of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Adolescent
Share to Communicable Disease Control

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to Public Health Surveillance

Share to SARS-CoV-2

Share to United States

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 34914670
DOI: 10.15585/mmwr.mm7050e1
PMCID: PMC8675659

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.PMID 34914670Read ↗

SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with Covid-19Semantic proximity Read ↗

SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19Semantic proximity Read ↗

Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.Semantic proximity Read ↗

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!Semantic proximity Read ↗

Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective.Semantic proximity Read ↗

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United States, January 2022–May 2023Semantic proximity Read ↗

SARS‐CoV‐2 Omicron variant: Characteristics and preventionSemantic proximity Read ↗

Omicron variant of SARS-CoV-2: a review of existing literature.Semantic proximity Read ↗

A Mini Review on SARS-COVID-19-2 Omicron Variant (B.1.1.529)Semantic proximity Read ↗

Omicron (B.1.1.529) variant: Development, dissemination, and dominanceSemantic proximity Read ↗

Omicron (B.1.1.529) SARS-CoV-2 Infection Fatality Rates: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.